BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34830786)

  • 1. Comparison of Different Systemic Therapeutic Regimes in Resectable Soft-Tissue Sarcoma-Results of a Network Meta-Analysis.
    Haussmann J; Matuschek C; Bölke E; Tamaskovics B; Corradini S; Wessalowski R; Maas K; Schmidt L; Orth K; Peiper M; Keitel V; Feldt T; Jensen BO; Luedde T; Fischer J; Knoefel WT; Ashmawy H; Pedotoa A; Kammers K; Budach W
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of Neoadjuvant and Adjuvant Therapy Compared With Surgery Alone for Resectable Esophageal Squamous Cell Carcinoma: A Systemic Review and Network Meta-Analysis.
    Ma Z; Yuan M; Bao Y; Wang Y; Men Y; Hui Z
    Front Oncol; 2021; 11():728185. PubMed ID: 34745950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. Sarcoma Meta-analysis Collaboration (SMAC).
    Sarcoma Meta‐analysis Collaboration (SMAC) ‐ see acknowledgement section for list of authors
    Cochrane Database Syst Rev; 2000; 2000(2):CD001419. PubMed ID: 10796873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults.
    Sarcoma Meta-analysis Collaboration (SMAC)
    Cochrane Database Syst Rev; 2000; (4):CD001419. PubMed ID: 11034717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.
    Blank O; von Tresckow B; Monsef I; Specht L; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007110. PubMed ID: 28447341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current trials and new aspects in soft tissue sarcoma of adults.
    Issels RD; Schlemmer M
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S4-8. PubMed ID: 12042982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma.
    Pervaiz N; Colterjohn N; Farrokhyar F; Tozer R; Figueredo A; Ghert M
    Cancer; 2008 Aug; 113(3):573-81. PubMed ID: 18521899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Perioperative Chemotherapy Timing in Conjunction With Postoperative External-Beam Radiation Therapy on Extremity Soft-Tissue Sarcomas Outcome.
    Mahmoud O; Dosch A; Kwon D; Pitcher JD; Conway S; Benedetto P; Fernandez G; Trent J; Temple HT; Wolfson AH
    Am J Clin Oncol; 2016 Oct; 39(5):528-34. PubMed ID: 24879472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma: A Network Meta-analysis.
    Pasquali S; Yim G; Vohra RS; Mocellin S; Nyanhongo D; Marriott P; Geh JI; Griffiths EA
    Ann Surg; 2017 Mar; 265(3):481-491. PubMed ID: 27429017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer.
    Rydzewska L; Tierney J; Vale CL; Symonds PR
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD007406. PubMed ID: 23235641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Efficacy of Neoadjuvant Versus Adjuvant Therapy for Resectable Esophageal Cancer Patients: A Systematic Review and Meta-Analysis.
    Xiao X; Hong HG; Zeng X; Yang YS; Luan SY; Li Y; Chen LQ; Yuan Y
    World J Surg; 2020 Dec; 44(12):4161-4174. PubMed ID: 32761259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration.
    Lancet; 1997 Dec; 350(9092):1647-54. PubMed ID: 9400508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
    Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
    Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.
    Issels RD; Lindner LH; Verweij J; Wust P; Reichardt P; Schem BC; Abdel-Rahman S; Daugaard S; Salat C; Wendtner CM; Vujaskovic Z; Wessalowski R; Jauch KW; Dürr HR; Ploner F; Baur-Melnyk A; Mansmann U; Hiddemann W; Blay JY; Hohenberger P; ;
    Lancet Oncol; 2010 Jun; 11(6):561-70. PubMed ID: 20434400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer.
    Rydzewska L; Tierney J; Vale CL; Symonds PR
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007406. PubMed ID: 20091632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma.
    Hu Q; Wang D; Chen Y; Li X; Cao P; Cao D
    Radiat Oncol; 2019 Jul; 14(1):120. PubMed ID: 31291998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant radiotherapy for Merkel cell carcinoma: A systematic review and meta-analysis.
    Petrelli F; Ghidini A; Torchio M; Prinzi N; Trevisan F; Dallera P; De Stefani A; Russo A; Vitali E; Bruschieri L; Costanzo A; Seghezzi S; Ghidini M; Varricchio A; Cabiddu M; Barni S; de Braud F; Pusceddu S
    Radiother Oncol; 2019 May; 134():211-219. PubMed ID: 31005218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases.
    Khoo E; O'Neill S; Brown E; Wigmore SJ; Harrison EM
    HPB (Oxford); 2016 Jun; 18(6):485-93. PubMed ID: 27317952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis.
    Malthaner RA; Wong RK; Rumble RB; Zuraw L;
    BMC Med; 2004 Sep; 2():35. PubMed ID: 15447788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Optimal Treatment for Resectable Esophageal Cancer: A Network Meta-Analysis of 6168 Patients.
    Yuan M; Bao Y; Ma Z; Men Y; Wang Y; Hui Z
    Front Oncol; 2021; 11():628706. PubMed ID: 33777777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.